Author information: (1)Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, United Kingdom. (2)Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, United Kingdom. (3)Department of Molecular Oncology, BC Cancer, part of the Provincial Health Services Authority, Vancouver, Canada. (4)Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada. (5)Department of Computer Science, University of British Columbia, Vancouver, Canada. (6)Department of Chemistry, University of Cambridge, Cambridge, United Kingdom. (7)School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom. (8)McGovern Institute, Departments of Biological Engineering and Brainand Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, United States. (9)Department of Oncology and Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom. (10)Súil Interactive Ltd, Dublin, United Kingdom. (11)Department of Oncology and Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland. (12)EMBL-European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, United Kingdom. (13)Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, United Kingdom. (14)Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, United States. (15)Herbert and Florence Irving Institute for Cancer Dynamics, Columbia University, New York, United States. (16)New York Genome Center, New York, United States. (17)Institute of Astronomy, University of Cambridge, Cambridge, United Kingdom. (18)Howard Hughes Medical Institute, Harvard University, Cambridge, United States. (19)Department of Physics, Harvard University, Cambridge, United States. (20)Department of Chemistry and Chemical Biology, Harvard University, Cambridge, United States. (#)Contributed equally